Illumina Inc.

87.62
2.83 (3.34%)
At close: Mar 21, 2025, 3:59 PM
87.59
-0.03%
After-hours: Mar 21, 2025, 06:59 PM EDT
3.34%
Bid 87
Market Cap 13.88B
Revenue (ttm) 4.36B
Net Income (ttm) -1.22B
EPS (ttm) -7.69
PE Ratio (ttm) -11.39
Forward PE 30.01
Analyst Buy
Ask 88
Volume 1,750,789
Avg. Volume (20D) 2,400,745
Open 83.74
Previous Close 84.79
Day's Range 84.10 - 87.85
52-Week Range 80.18 - 156.66
Beta 1.17

About ILMN

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequenci...

Sector Healthcare
IPO Date Jul 28, 2000
Employees 8,970
Stock Exchange NASDAQ
Ticker Symbol ILMN
Full Company Profile

Analyst Forecast

According to 18 analyst ratings, the average rating for ILMN stock is "Buy." The 12-month stock price forecast is $147.5, which is an increase of 68.34% from the latest price.

Stock Forecasts

Next Earnings Release

Illumina Inc. is scheduled to release its earnings on May 1, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-5.47%
Illumina shares are trading lower after Barclays d... Unlock content with Pro Subscription
1 month ago
-1.51%
Illumina shares are trading lower. The company reported Q4 financial results.